CDC has released supplemental information for providers about the 9-valent HPV vaccine. The document summarizes some of the recommendations included in the original Policy Note and provides additional guidance for issues that were not addressed previously but are likely to arise during the transition from quadrivalent HPV vaccine to 9-valent HPV vaccine.
More NACCHO Blogs
Stories from the Field
Stories from the Field provides a means for local health departments to share their experiences and demonstrate the value of public health.
The Preparedness Brief provides updates and information from NACCHO’s public health preparedness portfolio.